KZA 0.00% 8.0¢ kazia therapeutics limited

I agree, only a matter of weeks before OVATURE. If a phase III...

  1. 3,045 Posts.
    I agree, only a matter of weeks before OVATURE. If a phase III trial for a pan-acting cancer agent with an excellent safety profile can't excite the market then nothing will. Have a feeling many investors have just lost interest due to ongoing delays... but if results are positive, then we could be in for a really nice ride.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.